Ipca Laboratories Limited (BOM:524494)
1,845.05
-14.70 (-0.79%)
At close: Nov 20, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 467.78 billion as of November 20, 2026. Its market cap has increased by 27.39% in one year.
Market Cap
467.78B
Enterprise Value
479.15B
Revenue
104.80B
Global Rank
n/a
Country Rank
n/a
PE Ratio
34.05
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 467.78B, an increase of 14,432.97%. That is a compound annual growth rate of 22.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 467.78B | 29.95% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 747.32B |
| Alkem Laboratories | 619.94B |
| Gland Pharma | 549.34B |
| Ipca Laboratories | 466.56B |
| Emcure Pharmaceuticals | 443.66B |
| Ajanta Pharma | 414.52B |